BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 18515788)

  • 41. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Ceriotti C
    Curr Opin Cardiol; 2013 Jan; 28(1):50-4. PubMed ID: 23196776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patients.
    Marshall HJ; Griffith MJ
    Europace; 1999 Jan; 1(1):26-9. PubMed ID: 11220535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of echo-guided cardiac resynchronization pacing in patients undergoing "ablate and pace" therapy for permanent atrial fibrillation and effects of heart rate regularization and left ventricular resynchronization.
    Brignole M; Menozzi C; Botto GL; Mont L; Osca Asensi J; García Medina D; Oddone D; Navazio A; Luzi M; Iacopino S; De Fabrizio G; Proclemer A; Vardas P
    Am J Cardiol; 2008 Oct; 102(7):854-60. PubMed ID: 18805110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current role of atrioventricular junction (AVJ) ablation.
    Hoffmayer KS; Scheinman M
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):257-65. PubMed ID: 23078186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ablate and pace therapy for paroxysmal atrial fibrillation, too much too late.
    Kappenberger L
    Europace; 1999 Jan; 1(1):5-6. PubMed ID: 11220542
    [No Abstract]   [Full Text] [Related]  

  • 46. Atrioventricular Junction Ablation for Atrial Fibrillation.
    Patel D; Daoud EG
    Heart Fail Clin; 2016 Apr; 12(2):245-55. PubMed ID: 26968669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dynamic of the changes of the paced QT dispersion after ventricular pacemaker implantation (WIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Majewski J; Szczepkowski J; Dreher A; Bednarek J; Małecka B
    Przegl Lek; 2008; 65(2):61-7. PubMed ID: 18663902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation.
    Tops LF; Schalij MJ; Holman ER; van Erven L; van der Wall EE; Bax JJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1642-8. PubMed ID: 17045901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [What is the role of catheter ablation of the AV Junction and of the permanent cardiostimulation when all forms of atrial fibrillation are possible to treat selective catheter ablation?--Editorial].
    Fiala M
    Vnitr Lek; 2007 Sep; 53(9):919-22. PubMed ID: 18019654
    [No Abstract]   [Full Text] [Related]  

  • 50. [Destruction of the atrioventricular junction and implantation of synchronized atrial pacemaker in a patient with paroxysmal atrial fibrillation].
    Egorov DF; Vygovskiĭ AB; Podlesov AM; Iashin SM
    Klin Med (Mosk); 1990 Aug; 68(8):88-9. PubMed ID: 2084383
    [No Abstract]   [Full Text] [Related]  

  • 51. An assessment of the optimal ventricular pacing site in patients undergoing 'ablate and pace' therapy for permanent atrial fibrillation.
    Brignole M; Gammage M
    Europace; 2001 Apr; 3(2):153-6. PubMed ID: 11333055
    [No Abstract]   [Full Text] [Related]  

  • 52. Resumption of atrioventricular conduction by levosimendan after radiofrequency ablation of the AV node:
    Maury P; Baixas C; Roncalli J; Couderc P; Delay M; Pathak A; Galinier M
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1314-6. PubMed ID: 15461725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Just how stable are escape rhythms after atrioventricular junction ablation?
    Arora R; Spatz E; Vijayaraman P; Rosengarten M; Gross J; Kim S; Fisher J; Ferrick KJ
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):939-44. PubMed ID: 20487338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful catheter ablation to accessory atrioventricular pathway as cardiac resynchronization therapy in a patient with dilated cardiomyopathy.
    Iwasaku T; Hirooka K; Taniguchi T; Hamano G; Utsunomiya Y; Nakagawa A; Koide M; Ishizu T; Yamato M; Sasaki N; Yamamoto H; Kawaguchi Y; Mizuno H; Koretsune Y; Kusuoka H; Yasumura Y
    Europace; 2009 Jan; 11(1):121-3. PubMed ID: 19028709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Arrhythmias].
    Misaki T; Fukahara K
    Kyobu Geka; 2004 Jul; 57(8 Suppl):729-35. PubMed ID: 15362552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac pacing and atrial arrhythmias.
    Gross JN; Sackstein RD; Furman S
    Cardiol Clin; 1992 Nov; 10(4):609-17. PubMed ID: 1423376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation.
    Lau DH; Thiyagarajah A; Willems S; Rostock T; Linz D; Stiles MK; Kaye D; Kalman JM; Sanders P
    Heart Lung Circ; 2017 Sep; 26(9):934-940. PubMed ID: 28687248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Zankar A; Joglar JA; Naseem RH
    Cardiol Rev; 2007; 15(6):310-5. PubMed ID: 18090067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment.
    Heist EK; Ruskin JN
    Prog Cardiovasc Dis; 2006; 48(4):256-69. PubMed ID: 16517247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of atrial fibrillation in patients with heart failure.
    Efremidis M; Pappas L; Sideris A; Filippatos G
    J Card Fail; 2008 Apr; 14(3):232-7. PubMed ID: 18381187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.